Associate Professor Sam Forster’s research is focused on gaining a fundamental understanding of the microbial communities that inhabit our bodies. Termed the microbiome, these communities play an essential role in…… Read more
…Caroline GargettDr Jamie GearingDr Edward GilesDr Cristina GioghaRinky GiriDr Timothy GottschalkAssociate Professor Daniel GoughDr George GrigoriadisDr Raffi GugasyanDr Emily GulliverDr Shanti GurungProfessor Vincent HarleyDr Christopher HarpurAssociate Professor Craig HarrisonProfessor Elizabeth…… Read more
…also have inflammatory bowel diseases (IBD) – Crohn’s and ulcerative colitis. “I usually see Dr Edward Giles (Hudson Institute inflammation researcher and Monash Health consultant paediatric gastroenterologist) every two months, but at…… Read more
…study into new species of gut bacteria has been described as ‘game-changing’ for research worldwide. Dr Forster is collaborating with Dr Jaclyn Pearson and Dr Edward Giles to combine expertise…… Read more
…side effects, such as an increased risk of colorectal cancer and lymphoma. Dr Sam Forster, Dr Jaclyn Pearson and Dr Edward Giles hope their research will lead to more targeted…… Read more
…GS, Giles GG, Thomas PS, Morrison S, Johns DP, Knibbs LD, Zock JP, Marcon A, Garcia-Aymerich J, Erbas B, Jarvis D, Svanes C, Lodge CJ, Dharmage SC (2020) Lifetime risk…… Read more
…immune responses to helicobacter pylori. Methods Mol Biol. 2283:191-214. Chua N, Singh H, Lay J, Murray M, McDonald J, Craig SS, Giles EM (2021) Emergency presentations for gastrostomy complications are…… Read more
…Dr Ed Giles Crohn’s research: Dr Ed Giles Dr Ed Giles is leading two Crohn’s studies at Hudson Institute. One is investigating the relationship between the microbiome and Crohn’s. The…… Read more
…to revolutionise treatment of inflammatory bowel disease Dr Sam Forster NHMRC Ideas Grant: 2020–2023 Amount: $997,926 Co-investigators: Edward Giles Inflammatory bowel disease (IBD) incidence is increasing worldwide. It affects more…… Read more
…Gastroenterologist Dr Edward Giles from Monash Health, and the Adelaide-based biotechnology company BiomeBank to develop new therapies for IBD. With cutting-edge technologies, including the gut-on-a-chip, which allows individual gut microbiome…… Read more
